Navigation Links
NASA selects DNA Medicine Institute's Nanoscale Diagnostics Technology for Phase II SBIR
Date:1/28/2010

CAMBRIDGE, Mass., Jan. 28 /PRNewswire/ -- DNA Medicine Institute, a commercial organization focused on advancing human health through innovation, today announced it has been awarded a Phase II Small Business Innovation Research (SBIR) contract from the National Aeronautics and Space Administration (NASA).  The contract is designed to develop nanoscale diagnostic technologies that facilitate whole health analysis in a single drop of blood.  The Institute will develop assays for assessment of bone loss, immune function, cardiac health, liver function, and lipid status.  The nanoscale diagnostic platform is designed to make hospital tests, currently performed on large machines with trained personnel, possible under any scenario.  This includes confined space flight environments and other field settings where medical information is vital, but inaccessible.  The Institute envisions that this technology will be used in conjunction with its Universal Blood Sensor platform designed to shrink a hospital testing lab onto a handheld, point-of-care device.

"We are pleased to work with NASA in developing technologies for monitoring crew health during space flight, including journeys to the space station and other manned space missions," said Eugene Y. Chan, M.D., President and Chief Scientific Officer of the DNA Medicine Institute.  "This funding will allow us to develop innovations for diagnosing medical conditions in unique environments with minimal amounts of blood and reagents."

The DNA Medicine Institute was awarded a Phase I NASA SBIR grant in 2008.  During this Phase I project, the Institute met key milestones for developing novel nanoscale diagnostic technologies.

About DNA Medicine Institute

The DNA Medicine Institute is a commercial organization whose mission is to advance patient care, alleviate human suffering, and treat disease through innovation.  Founded by Eugene Y. Chan, M.D., its core beliefs are that successful, innovative commercial products can make a long-lasting impact on patient care.  It currently does research on intuitive medical devices, smartly designed drugs, and powerful research instrumentation.  One of these is the Universal Blood Sensor, a technology designed to perform a full health analysis of a person, anywhere, anytime, and with a single drop of blood.  The DNA Medicine Institute's multi-faceted approach to innovation draws upon diverse fields including medicine, nanotechnology, genomics, biophysics, biochemistry, molecular biology, and advanced engineering.  For more information, visit:  www.dnamedinstitute.com.

SOURCE DNA Medicine Institute


'/>"/>
SOURCE DNA Medicine Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Central Garden & Pet Selects SiteHawk as Its MSDS Management Provider
2. NewYork-Presbyterian Hospital Selects Omnicell for Medication Management
3. Virtua Selects Nuvon, Inc. as its Device Connectivity and Integration Solution Provider
4. Legacy Health Selects Allscripts Care Management for Hospitals and Post-Acute Care Facilities
5. Catholic Health Initiatives Selects Allscripts Electronic Health Record for Over 1000 Physicians in 19 States
6. Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management
7. New Mexico VA Health Care System Selects Sensotech Wireless Temperature Monitoring System
8. bioMerieux Selects Brainware to Automate Accounts Payable
9. Blue Cross Blue Shield of Michigan Selects Kevin Klobucar to Lead Blue Care Network as President
10. Lifespace Communities Selects StaffKnex Software for Nurse Scheduling and Employee Communications
11. Baptist Health System Selects HealthScreen Disease Management for Employee Health Management Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... ... February 17, 2017 , ... Butler Mobility invited Ken Matthews to ... other Butler products. Ken was impressed with the safety and reliability of the ... product on his show. This endorsement by Ken Matthews can be heard on ...
(Date:2/18/2017)... ... 2017 , ... Park Cities Pet Sitter President, Joette White, has been featured ... network. The episode, which was posted this week, features a 30-minute interview of ... Park Cities Pet Sitter’s being awarded the 2017 National Association of Professional Pet Sitter’s ...
(Date:2/18/2017)... (PRWEB) , ... February 18, 2017 , ... ... today provides the latest information and contact points to easily connect elderly veterans ... care, assisted living, and elder-care funding. It also conveys material on this year's ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... has not kept pace. Enovate Medical has introduced an innovative workstation designed to ... of supporting nurses, the Encore Mobile EHR Workstation offers a lightweight, highly mobile, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Wells Pharmacy ... electronic prescribing of controlled and non-controlled substances plus the ability to manage orders ... the United States now accept electronic prescriptions, according to the Office of the ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... Feb. 16, 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ... focused on the development and commercialization of innovative ... announced that Vincent J. Angotti has ... of the company,s board of directors, effective Monday, ... decades of experience leading executive and commercial teams ...
(Date:2/16/2017)... , Feb. 16, 2017 HealthInfoNet (HIN), ... it is partnering with Orion Health on the implementation of ... Maine residents, clinical information and is ... over 500 ambulatory care sites. Pending final review ... Health,s Amadeus , a precision medicine platform that leverages ...
(Date:2/16/2017)... 16, 2017 Die Stärkung ... haben in der Medizinproduktebranche oberste Priorität. Während die ... den Blick auf unmittelbar anstehende regulatorische Änderungen auf ... diesen Regionen. ... Aufsichtsbehörden, Hersteller von ...
Breaking Medicine Technology: